David B. Goldstein, Ph.D. | |
---|---|
Nationality | United States |
Scientific career | |
Fields | Geneticist |
Institutions | Columbia University |
David Goldstein is an American human geneticist. He trained in theoretical population genetics at Stanford University (PhD 1994), where he worked with Marcus Feldman and Luca Cavalli Sforza. Goldstein is founding Director of the Institute for Genomic Medicine at the Columbia University Medical Center, Professor of Genetics and Development and directs the genomics core of Epi4K and administrative cores of Epi4K with Dan Lowenstein and Sam Berkovic.
Goldstein's primary research interests include human genetic diversity, the genetics of disease, and pharmacogenetics. The Goldstein group and collaborators have discovered a number of disease causing genes and syndromes, in particular in neurological and infectious diseases including:
1996-1999: Lecturer, University of Oxford
1999-2005: Wolfson Professor of Genetics, University College London
2005–2014: Richard and Pat Johnson Distinguished University Professor of Genetics, Microbiology, and Biology, Duke University and Director for the Center for Human Genome Variation
2014-present: John E. Borne Professor of Medical and Surgical Research, Columbia University and Director, Institute for Genomic Medicine, Columbia University Medical Center
Goldstein was elected a fellow of AAAS in 2013, received the University of North Carolina at Chapel Hill IPIT award for clinical services in 2012, and was a recipient of one of the first seven nationally awarded Royal Society / Wolfson research merit awards in the UK for his work in human population genetics. In 2013, Goldstein chaired the Gordon Research Conference in Human Genetics, and he is currently serving on the Advisory Council at the National Institute of Neurological Disorders and Stroke at NIH.